LobbyingNeuros Medical lobbying by quarter
Neuros Medical's latest lobbying report covers Q2 2026, at $210K. The four quarters Q4 2025–Q3 2026 total $410K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Defense.
Neuros Medical
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $410K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $10K | 1 |
| Q1 2023 | $0 | 0 |
| Q2 2023 | $0 | 0 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $200K | 2 |
| Q2 2026 | $210K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$141.7K · 5 reports
- Defense$136.7K · 4 reports
- Veterans$136.7K · 4 reports
- Health issues$5,000 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseNeuros Medical | $230K | 2 quarters |
| DB3 | $180K | 2 quarters |
| Galileo Consulting Group | $10K | 1 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | DB3 | $90K |
| 07/15for Q2 | In-house | $120K |
| 04/21for Q1 | In-house | $110K |
| 04/20for Q1 | DB3 | $90K |
| 04/20for Q1 | In-house | Under $5,000 |
| 02/10for Q1 | DB3 | Under $5,000 |
| 23/04/17for Q4 2022 | Galileo Consulting Group | $10K |
| 23/01/19for Q4 2022 | Galileo Consulting Group | $10K |